Search

everythinglearnresearchcommunity

for

Search:↓

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Higher serum androgens contribute to male pattern baldness.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

No link found between hair loss severity and PSA levels in men.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

No link between hair loss severity and PSA levels in men.

Dutasteride reduces DHT more effectively than finasteride.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

CT scans can find serious prostate cancer even when PSA levels are low.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.